BIO Statement on Confirmation of Ms. Seema Verma

March 13, 2017

BIO congratulates Ms. Seema Verma on her successful confirmation to lead the Centers for Medicare and Medicaid Services (CMS). We look forward to working with her and Secretary Price to advance patient-centric policies that promote affordable access to medicines and continued innovation.

Discover More

BIO Launches “The Fight of Our Lives,” a National…

WASHINGTON, DC – Today, the Biotechnology Innovation Organization (BIO) announced the launch of The Fight of Our Lives, a new national campaign focused on the stories behind biotechnology breakthroughs, the patients whose lives depend on them…

Learn more

BIO Statement on the Section 232 Pharmaceutical…

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on Section 232 Pharmaceutical Proclamation.“A thriving American biotechnology ecosystem is essential to…

Learn more

BIO Statement on Passage of Legislation…

WASHINGTON, D.C. - Brad Zakes, senior vice president for emerging companies and economic affairs at the Biotechnology Innovation Organization (BIO), released the following statement on passage of legislation reauthorizing the SBIR/STTR program:"The…

Learn more